BioPharma Dive·· 4 hours agoPickScore53
From strategy to scale: How Saudi Arabia is building a biotech ecosystem
In brief
A BioPharma Dive sponsored article traces Saudi Arabia's biotech ecosystem from strategy to execution: the three-day RGMBS summit in September produced more than 40 agreements and initiatives, with disclosed values totaling over 5 billion riyals (about $1.33 billion).
Why it matters
The article tracks Saudi biotech progress across R&D, clinical, manufacturing and regulation, giving companies a list of verifiable indicators for market entry.
Source: BioPharma Dive · biopharmadive.com